Apogee Therapeutics Inc. (APGE)
NASDAQ: APGE
· Real-Time Price · USD
39.49
-0.87 (-2.16%)
At close: May 23, 2025, 3:59 PM
39.48
-0.03%
After-hours: May 23, 2025, 04:20 PM EDT
-2.16% (1D)
| Bid | 37 |
| Market Cap | 2.35B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -150.05M |
| EPS (ttm) | -3.61 |
| PE Ratio (ttm) | -10.94 |
| Forward PE | -7.35 |
| Analyst | Buy |
| Ask | 42.55 |
| Volume | 313,595 |
| Avg. Volume (20D) | 703,544 |
| Open | 39.35 |
| Previous Close | 40.36 |
| Day's Range | 39.15 - 39.95 |
| 52-Week Range | 26.20 - 63.50 |
| Beta | 1.72 |
About APGE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol APGE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for APGE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+6.14%
Apogee Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
6 months ago
-5.14%
Apogee Therapeutics shares are trading lower. The company reported Q3 financial results.
